Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 0904-6581

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 0904-6581). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

62240ecb B29e 41fe 8f9e 05ee47d279f2 00

Label for Esomeprazole Magnesium delayed-release capsules USP, 40 mg strength, 100 capsules per unit dose package from Major Pharmaceuticals. The label includes the NDC numbers 0904-6581 and 0904-6581-61, dosage form as capsule, and storage instructions. It indicates the product is prescription-only and includes a medication guide for the pharmacist to dispense.*

FDA Label Image

62240ecb B29e 41fe 8f9e 05ee47d279f2 01

Label for Esomeprazole Magnesium delayed-release capsules USP 40 mg by Major Pharmaceuticals. The label states it is a unit dose product with 100 capsules, prescription only, and includes instructions for pharmacists to dispense with medication guide. Manufacturer and distributor details, dosage information, storage instructions, and barcode are also visible.*

FDA Label Image

Figure1 (Figure1)

Chemical structure of esomeprazole magnesium trihydrate, showing two esomeprazole molecules coordinated with a magnesium ion (Mg2+) and three water molecules (3 H2O).*

FDA Label Image

Figure2 (Figure2)

A line chart showing the percent maintained over time (months 0 to 6) for four groups: Esomeprazole 40 mg, 20 mg, 10 mg, and placebo. The y-axis represents percent maintained and the x-axis represents months. The chart compares maintenance rates among the different dosages and placebo over a six-month period.*

FDA Label Image

Figure3 (Figure3)

A line graph depicting percent maintained over six months for Esomeprazole at different doses (40 mg, 20 mg, and 10 mg) compared to placebo. The x-axis represents time in months, and the y-axis shows the percent maintained, illustrating higher maintenance with the 40 mg dose.*

FDA Label Image

Figure4 (Figure4)

A line graph depicting the percent of patients symptom-free over a 28-day period. It compares three groups: Esomeprazole 40 mg, Esomeprazole 20 mg, and a placebo, showing their performance across the study days.*

FDA Label Image

Figure5 (Figure5)

A line graph showing the percent of patients symptom-free over a 28-day diary period for three groups: Esomeprazole 40 mg, Esomeprazole 20 mg, and placebo. The graph tracks daily improvement in symptoms, with higher percentages noted for the 40 mg and 20 mg Esomeprazole groups compared to placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.